Emergent BioSolutions Inc
NYSE:EBS
Emergent BioSolutions Inc
NYSE:EBS
Price:
11.08
USD
1.09%
Market Closed
Market Cap:
$581.9m
Wall Street
Price Targets
EBS Price Targets Summary
Emergent BioSolutions Inc
Emergent BioSolutions Inc
Wall Street analysts forecast EBS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
EBS
is 13.77 USD
with a low forecast of 12.12 USD and a high forecast of 15.75 USD.
Lowest
Price Target
12.12
USD
9% Upside
Average
Price Target
13.77
USD
24% Upside
Highest
Price Target
15.75
USD
42% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EBS's stock price target?
Price Target
13.77
USD
13.77
USD
According to Wall Street analysts, the average 1-year price target for
EBS
is 13.77 USD
with a low forecast of 12.12 USD and a high forecast of 15.75 USD.
What is Emergent BioSolutions Inc's Revenue forecast?
Projected CAGR
-13%
-13%
For the last 13 years the
compound annual growth rate for
Emergent BioSolutions Inc's revenue is
11%.
The projected
CAGR
for the next 3 years is
-13%.
